Reis J, Vieira B, Cunha Neto A, Castro V, Figueiredo E
Can J Infect Dis Med Microbiol. 2022; 2022:1351983.
PMID: 36249588
PMC: 9568363.
DOI: 10.1155/2022/1351983.
Weinstein M, Mirrett S, Kannangara S, Monahan J, Harrell L, Wilson A
J Clin Microbiol. 2004; 42(8):3747-51.
PMID: 15297525
PMC: 497596.
DOI: 10.1128/JCM.42.8.3747-3751.2004.
Jones R
J Clin Microbiol. 2001; 39(10):3810-1.
PMID: 11599520
PMC: 88444.
DOI: 10.1128/JCM.39.10.3810-3811.2001.
Weinstein M
J Clin Microbiol. 2001; 39(7):2729-31.
PMID: 11427608
PMC: 88224.
DOI: 10.1128/JCM.39.7.2729-2731.2001.
Hof H, Nichterlein T, Kretschmar M
Clin Microbiol Rev. 1997; 10(2):345-57.
PMID: 9105758
PMC: 172923.
DOI: 10.1128/CMR.10.2.345.
Enhanced activity of the combination of penicillin G and gentamicin against penicillin-resistant viridans group streptococci.
Cercenado E, Diaz M, Sanchez-Carrillo C, Vicente T, Bernaldo De Quiros J
Antimicrob Agents Chemother. 1995; 39(12):2816-8.
PMID: 8593029
PMC: 163039.
DOI: 10.1128/AAC.39.12.2816.
Antimicrobial chemotherapy of human infection due to Listeria monocytogenes.
Jones E, MacGowan A
Eur J Clin Microbiol Infect Dis. 1995; 14(3):165-75.
PMID: 7614955
DOI: 10.1007/BF02310351.
Pharmacokinetics and bacteriological efficacy of N-formimidoyl thienamycin in experimental Escherichia coli meningitis.
Patamasucon P, McCracken Jr G
Antimicrob Agents Chemother. 1982; 21(3):390-2.
PMID: 7049073
PMC: 181901.
DOI: 10.1128/AAC.21.3.390.
Lack of in vivo and in vitro bactericidal activity of N-formimidoyl thienamycin against enterococci.
Auckenthaler R, Wilson W, Wright A, Washington 2nd J, Durack D, GERACI J
Antimicrob Agents Chemother. 1982; 22(3):448-52.
PMID: 6958215
PMC: 183764.
DOI: 10.1128/AAC.22.3.448.
[N-formimidoyl-thienamycin: in vitro activity in bacteria with resistance to beta-lactam antibiotics or gentamicin].
Bartmann K, Tarbuc R
Infection. 1982; 10(6):361-70.
PMID: 6818153
DOI: 10.1007/BF01642300.
Synergy of imipenem or penicillin G and aminoglycosides against enterococci isolated from patients with infective endocarditis.
Indrelie J, Wilson W, Matsumoto J, GERACI J, Washington 2nd J
Antimicrob Agents Chemother. 1984; 26(6):909-12.
PMID: 6596907
PMC: 180048.
DOI: 10.1128/AAC.26.6.909.
In vitro activity of imipenem--a review.
Braveny I
Eur J Clin Microbiol. 1984; 3(5):456-62.
PMID: 6389125
DOI: 10.1007/BF02017375.
In vitro activity and mechanism of action of A21978C1, a novel cyclic lipopeptide antibiotic.
Eliopoulos G, Thauvin C, Gerson B, Moellering Jr R
Antimicrob Agents Chemother. 1985; 27(3):357-62.
PMID: 3994349
PMC: 176277.
DOI: 10.1128/AAC.27.3.357.
Antimicrobial susceptibilities of Listeria monocytogenes strains isolated from 1958 to 1982 in Sweden.
Larsson S, Walder M, Cronberg S, Forsgren A, Moestrup T
Antimicrob Agents Chemother. 1985; 28(1):12-4.
PMID: 3929675
PMC: 176300.
DOI: 10.1128/AAC.28.1.12.
Lack of synergism of ampicillin and gentamicin in experimental listeriosis.
Hof H, Guckel H
Infection. 1987; 15(1):40-1.
PMID: 3570481
DOI: 10.1007/BF01646117.
Imipenem/cilastatin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.
Clissold S, Todd P
Drugs. 1987; 33(3):183-241.
PMID: 3552595
DOI: 10.2165/00003495-198733030-00001.
In vitro and in vivo studies of imipenem-cilastatin alone and in combination with gentamicin against Listeria monocytogenes.
Kim K
Antimicrob Agents Chemother. 1986; 29(2):289-93.
PMID: 3087277
PMC: 176393.
DOI: 10.1128/AAC.29.2.289.
In vitro studies of plasmid-mediated penicillinase from Streptococcus faecalis suggest a staphylococcal origin.
Murray B, Foster S, Brunton J, Harford P
J Clin Invest. 1986; 77(1):289-93.
PMID: 3080475
PMC: 423338.
DOI: 10.1172/JCI112289.
Antibiotic combinations: should they be tested?.
Eliopoulos G, Eliopoulos C
Clin Microbiol Rev. 1988; 1(2):139-56.
PMID: 3069193
PMC: 358039.
DOI: 10.1128/CMR.1.2.139.
Antibiotic susceptibilities of Listeria: in vitro studies.
Espaze E, Reynaud A
Infection. 1988; 16 Suppl 2:S160-4.
PMID: 3047066
DOI: 10.1007/BF01639741.